In our newest episode, we’re updating you on all things COVID-19 and introducing you to a medical pioneer. Prof. Dror Mevorach, director of the Rheumatology Research Center and head of one of the COVID units at Hadassah Medical Organization is at the forefront of a new experimental Israeli drug called Allocetra™. It’s helping critically ill COVID-19 patients stay alive. Hear more about the drug, the clinical trials and how Hadassah hospitals are managing the mental well being of its staff during this time.
Hadassah On Call: New Frontiers in Medicine
New Hope in the Fight Against COVID-19
Search Results placeholder